agilon health, Inc. (AGL)
NYSE
Closed
Oct 8, 2026
Day's Range
82.0652 wk Range
7.48Overview - AGL - agilon health, Inc.
Key Statistics
Valuation
Enterprise Value
1.20B
P/E (Trailing)
‪-3.39‬
P/E (Forward)
‪25.24‬
PEG Ratio
‪0.02‬
Price / Sales (TTM)
‪0.22‬
Price / Book
‪5.95‬
EV / EBITDA
‪-5.02‬
Profitability
Gross Margin
‪7.16%‬
Profit Margin
‪-3.92%‬
Operating Margin
‪1.29%‬
Return on Assets
‪-9.61%‬
Return on Equity
‪-78.94%‬
Ownership
Shares Outstanding
16.78M
Float
10.92M
Short % of Shares Outstanding
‪9.98%‬
Held by Insiders
‪5.04%‬
Held by Institutions
‪96.53%‬
Price stats
Beta
‪3.03‬
50-Day Avg
‪95.41‬
200-Day Avg
‪56.29‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 115.08‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AGL - agilon health, Inc.
Peers - AGL - agilon health, Inc.
Peer Comparison
Compared with companies in Medical Care Facilities listed on NYSE.
Profile Summary - AGL - agilon health, Inc.
About
agilon health, Inc. is a healthcare services company focused on supporting primary care physicians in managing senior patients through value-based care arrangements. The company provides a platform that helps physician groups coordinate care, manage total patient health needs, and operate under capitated reimbursement…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
